MAJI — Exousia Pro Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $2.21m
- $2.46m
Annual cashflow statement for Exousia Pro, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2011 April 30th | 2012 April 30th | 2018 April 30th | 2019 April 30th | 2020 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.101 | -6.07 | -0.001 | -0.125 | -0.436 |
| Non-Cash Items | 0 | 5.8 | -0.001 | 0 | 0.034 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.036 | 0.06 | 0.001 | 0.116 | 0.233 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.064 | -0.215 | -0.001 | -0.009 | -0.17 |
| Capital Expenditures | 0 | -0.25 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.25 | 0 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | 0 | 0.025 | 0 | 0 | -0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.13 | 0.15 | 0 | 0.008 | 0.17 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.066 | -0.065 | -0.001 | -0.002 | 0 |